RTW Investments

New York, New York
cb
Founded in 2009, RTW Investments is a venture capital firm based in New York, New York. The firm seeks to invest in the life sciences, big data, and digital health sectors.
Founded:2009
Firm Location:New York, New York
Investor Firms That Co-Invest with RTW Investments
Qiming Venture PartnersGV (Google Ventures)Domain AssociatesForbion
RTW Investments Team
Photo of Ovid Amadi, Analyst at RTW Investments
Ovid Amadi
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
to see your intro paths to Ovid
Photo of James Bellush, Analyst at RTW Investments
James Bellush
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in BioTech (Series A)
to see your intro paths to James
Photo of Lauren Cujé, Senior Associate at RTW Investments
Lauren Cujé
RTW Investments·Senior Associate
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Lauren
Photo of Peter Fong, Managing Director at RTW Investments
Peter Fong
RTW Investments·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
to see your intro paths to Peter
Photo of Joshua Kennedy-Smith, Managing Director at RTW Investments
Joshua Kennedy-Smith
RTW Investments·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
to see your intro paths to Joshua
Photo of Chris Liu, Analyst at RTW Investments
Chris Liu
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in BioTech (Series A)
to see your intro paths to Chris
Photo of Sabera Loughran, Partner at RTW Investments
Sabera Loughran
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in FinTech (Seed), Investors in New York City (Other Lists), Investors in FinTech (Series A), Investors in FinTech (Series A), Investors in FinTech (Seed)
to see your intro paths to Sabera
Photo of Paul Lu, Managing Director at RTW Investments
Paul Lu
RTW Investments·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Paul
Photo of Tony Nguyen, Analyst at RTW Investments
Tony Nguyen
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in Advertising (Series A), Investors in Advertising (Seed), Investors in Pharmaceuticals (Seed), Investors in Advertising (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in Advertising (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Tony
Photo of Piratip Pratumsuwan, Managing Director at RTW Investments
Piratip Pratumsuwan
RTW Investments·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Piratip
Photo of Stephanie Sirota, Partner at RTW Investments
Stephanie Sirota
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
to see your intro paths to Stephanie
Photo of Sebastian Trousil, Principal at RTW Investments
Sebastian Trousil
RTW Investments·Principal
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A)
to see your intro paths to Sebastian
Photo of Connor Williams, Analyst at RTW Investments
Connor Williams
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in New York City (Other Lists), Investors in BioTech (Series A)
to see your intro paths to Connor
Photo of Roderick Wong, Managing Partner at RTW Investments
Roderick Wong
RTW Investments·Managing Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Roderick
Photo of Naveen Yalamanchi, Partner at RTW Investments
Naveen Yalamanchi
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
to see your intro paths to Naveen